Navigation Links
Pathogenica Collaborates With University of Groningen and Amphia Hospital to Reduce Nosocomial Infections

Boston, MA (PRWEB) July 11, 2013

Pathogenica, Inc. announced that teams from the University Medical Center Groningen (UMCG) and Amphia Hospital in the Netherlands are pioneering the use of the company’s HAI BioDetection Kit to prevent and control nosocomial infections in their facilities.

With approx. 1,400 beds each, both Amphia and UMCG are among the largest hospitals in the world. Pathogenica’s CEO Adeyemi Adesokan remarked, “With UMCG being one of the world’s largest transplant centers and Amphia’s impressive track record with MRSA hygiene, both of these hospitals are models of excellence in infection control. We’re proud to be working with these trusted leaders in their fields to demonstrate the real-world value of our technology.”

In Groningen, the Department of Medical Microbiology and Infection Prevention (MMB) is piloting the use of Pathogenica’s solution for active surveillance of common drug-resistant bacteria with a focus on Intensive Care Units. Crucial for this approach is the availability of a next-generation sequencing platform, and for this project, the MBB is evaluating use of the Ion PGM Sequencer using data obtained in the “Innovation Laboratory” of Dr. John Rossen and Dr. Bhanu Sinha.

“Our mission is to have eyes for the invisible in order to further improve our care and patient safety,” said Professor Alex Friedrich, Chair of Medical Microbiology and Infection Prevention at UMCG. “The combination of Pathogenica’s technology with a state-of-the art next generation sequencing platform promises same or next-day turnaround for identification of both strain and drug-resistance information about a bacterial infection or colonization.”

In Breda, the team of Professor Jan Kluytmans, Head of Infection Control and Microbiology at Amphia Ziekenhuis, has also been assessing Pathogenica's HAI BioDetection Kit in the work up of an outbreak of multi-resistant E. coli. “The complex epidemiology of multi-resistant Enterobacteriaceae requires technology that can both address the molecular fingerprint of bacteria as well as the resistance genes involved,” said Kluytmans, who is also the incoming Head of the Dutch National Association for Microbiology. “Pathogenica is one of the first to accomplish the two in one assay.” The ongoing research is using the Ion PGM in combination with Pathogenica’s software to analyze a collection of outbreak-associated isolates.

Pathogenica’s HAI BioDetection kit is a research use only test that enables identification and sub-typing of 12 bacterial species responsible for over 95% of hospital acquired infections. The sequence-based solution is comprised of a multiplexed assay with automated analysis software. Pathogenica’s technology has the capability to bypass the requirement of bacterial isolation and culture, drastically expediting workflow, and can simultaneously process over a dozen samples per sequencing run, with turnaround from extracted DNA to interpreted result in roughly half a day. Species identified by the kit include (but not be limited to): A. baumannii, C. difficile, E. coli, K. pneumonia, P. aeruginosa, and S. aureus. For a full list of species and resistance genes identified by the kit, see the Pathogenica website.

All products referenced are for Research Use Only. Not intended for diagnostic uses.

About Pathogenica

Pathogenica combines the power of Cloud-based DNA sequencing analysis and next-generation DNA sequencing to revolutionize pathogen identification and enable real-time bio-surveillance. Its DxSeq™ platform offers new applications in health services through rapid multiplex identification of pathogens and drug resistance genes. Pathogenica’s high throughput pathogen identification system performs rapid and highly sensitive identification of a wide variety of biomarkers using a common assay protocol.

About UMCG

The University Medical Center Groningen is one of the largest hospitals in the Netherlands and the only academic center in the Netherlands that performs all transplantations. Within UMCG, the Department of Medical Microbiology and Infection Prevention (MMB) has primary responsibility to protect patients against infections, to perform diagnostics of infectious diseases and to provide advice for optimal antimicrobial therapy. For this purpose, the department uses state of the art technologies in diagnostics and epidemiology of infectious diseases. It has a high level of expertise in antibiotic resistance (MRSA, VRE, ESBL) in hospitals and the community. The department coordinates several large national and international as well as cross-border networks focusing on molecular epidemiology of antimicrobial resistance, zoonotic diseases/infections, infection control, and host-virus/bacterium interaction.

About Amphia Hospital

Amphia Ziekenhuis is one of the best and largest general clinical hospitals in the Netherlands. In addition to offering superior patient care, the hospital also provides training and research in core disciplines. More than 250 medical specialists, 4,600 employees and 290 volunteers constantly work to improve the quality of care and the sense of reassurance felt by the patients. The hospital operates from several locations in Breda, in the southern part of the Netherlands.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Professor collaborates on most comprehensive analyses of NSAIDs and coxibs
2. WEDI Collaborates with OCR to Provide Omnibus HIPAA/HITECH Final Rule Summer Webinar Series
3. CHOP collaborates with Pfizers Centers for Therapeutic Innovation to speed pediatric R & D
4. Sanford-Burnham collaborates with 5 Florida-based research organizations
5. University of Southern Mississippi Professor Collaborates with Houston Police for Eyewitness Research Study
6. ICA Fellow, Dafna Lemish, collaborates with UNICEF on child development initiative
7. Colleen’s Dream Foundation's First ‘Young Investigator’ Grant Directed to Dr. Felix Zeppernick of Johns Hopkins University
8. Rutgers University launches neuroscience consortium
9. Race apparently a factor in sleep apnea, Wayne State University researcher finds
10. University of New England and Partners Celebrate Opening of Portland Community Health Center at Riverton June 20 for Underserved Populations
11. University of Western States Celebrates Graduates at 199th Commencement at Oregon Convention Center
Post Your Comments:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine ... Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners ... with extensive sequencing and genomics experience, as Vice President of North American Capital Sales ... be responsible for leading the sales team in the commercialization of the HTG EdgeSeq ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced today ... its e-clinical software solution of choice.  This latest ... possible value to their clients by offering a ... preferred relationship establishes nowEDC as the EDC platform ... MedSource,s full-service clients.  "nowEDC has long been a ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
Breaking Medicine Technology: